By Steve Benen Last week, Robert F. Kennedy Jr., a conspiracy theorist whom Republicans put in charge of the Department of Health and Human Services, left little doubt that he would soon announce ...

PARIS, March 31 (Reuters) - France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the ...

Thousands of federal workers were bracing for pink slips Friday as Health and Human Services Secretary Robert F. Kennedy Jr. begins dismantling the sprawling federal agency responsible for ...

The Formula One legend’s health has been shrouded in secrecy ever since his skiing accident in December 2013 (Picture: Lars Baron/Bongarts/Getty Images) A major update into Michael Schumacher ...

Merck & Co.’s subcutaneous (SC) formulation of Keytruda has matched up to the original intravenous (IV) version on two blood concentration measurements, paving way for a potential FDA approval ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

Police are investigating the incident that took place at about 6 p.m. Sunday in an apartment building near Florence Boulevard and Browne Street. Omaha Police officers were called to the scene of ...

After that, Merck has an animal health segment that earned ~$6bn last year, or 9% of revenues, diabetes segment that earned $2.3bn, or 4% of revenues, virology segment, $1.8bn, 2% of revenues ...

Merck has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite this ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...

Apple last year introduced new hearing health features for its AirPods Pro 2 wireless earbuds. Since the features require approval from health regulators, they’ve been rolled out region by region.

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, the US drugmaker’s second recent foray into China for a novel medicine.